TEST BANK PHARMACOLOGY A PATIENT-CENTERED NURSING PROCESS
APPROACH, 11TH EDITION BY LINDA E. MCCUISTION CHAPTER 1-58
,Table Of Contents
Chapter 01: The Nursing Process And Patient-Centered Care...................................................................... 4
Chapter 02: Drug Development And Ethical Considerations ...................................................................... 11
Chapter 03: Pharmacokinetics And Pharmacodynamics ............................................................................ 20
Chapter 04: Pharmacogenetics ................................................................................................................... 38
Chapter 05: Complementary And Alternative Therapies ........................................................................... 42
Chapter 06: Pediatric Considerations ......................................................................................................... 48
Chapter 07: Geriatric Considerations ......................................................................................................... 57
Chapter 08: Drugs In Substance Use Disorder ............................................................................................ 63
Chapter 09: Safety And Quality................................................................................................................... 70
Chapter 10: Drug Administration ................................................................................................................ 78
Chapter 11: Drug Calculations .................................................................................................................... 84
Chapter 12: Fluid Volume And Electrolytes ................................................................................................ 89
Chapter 13: Vitamin And Mineral Replacement ....................................................................................... 100
Chapter 14: Nutritional Support ............................................................................................................... 109
Chapter 15: Adrenergic Agonists And Antagonists ................................................................................... 118
Chapter 16: Cholinergic Agonists And Antagonists .................................................................................. 125
Chapter 17: Stimulants ............................................................................................................................. 133
Chapter 18: Depressants ........................................................................................................................... 139
Chapter 19: Antiseizure Drugs .................................................................................................................. 147
Chapter 20: Drugs For Parkinsonism And Alzheimer Disease................................................................... 155
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms .................................................... 163
Chapter 22: Antipsychotics And Anxiolytics ............................................................................................. 170
Chapter 23: Antidepressants And Mood Stabilizers ................................................................................. 179
Chapter 24: Antiinflammatories ............................................................................................................... 188
Chapter 25: Analgesics .............................................................................................................................. 197
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins .......................................................... 205
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides... 211
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones Mccuistion: ........... 216
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics ..................................................................... 221
Chapter 30: Antituberculars, Antifungals, And Antivirals ......................................................................... 227
Chapter 31: Antimalarials, Anthelmintics, And Peptides .......................................................................... 237
Chapter 32: HIV- And AIDS-Related Drugs ................................................................................................ 241
,Chapter 33: TrCorrect Answerplant Drugs................................................................................................ 246
Chapter 34: Vaccines................................................................................................................................. 249
Chapter 35: Anticancer Drugs ................................................................................................................... 255
Chapter 36: Targeted Therapies To Treat Cancer ..................................................................................... 260
Chapter 37: Biologic Response Modifiers ................................................................................................. 265
Chapter 38: Upper Respiratory Disorders................................................................................................. 271
Chapter 39: Lower Respiratory Disorders ................................................................................................. 278
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics ..................................................... 288
Chapter 41: Diuretics ................................................................................................................................ 299
Chapter 42: Antihypertensives ................................................................................................................. 305
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics................................................................ 314
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow Mccuistion: ................. 324
Chapter 45: Gastrointestinal Tract Disorders ........................................................................................... 332
Chapter 46: Antiulcer Drugs...................................................................................................................... 342
Chapter 47: Eye And Ear Disorders ........................................................................................................... 352
Chapter 48: Dermatologic Disorders ........................................................................................................ 357
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders ....................................................... 364
Chapter 50: Antidiabetics ......................................................................................................................... 376
Chapter 51: Urinary Disorders .................................................................................................................. 385
Chapter 52: Pregnancy And Preterm Labor .............................................................................................. 393
Chapter 53: Labor, Delivery, And Postpartum .......................................................................................... 403
Chapter 54: Neonatal And Newborn ........................................................................................................ 410
Chapter 55: Women’s Reproductive Health ............................................................................................. 413
Chapter 56: Men’s Health And Reproductive Disorders ........................................................................... 422
Chapter 57: Sexually TrCorrect Answermitted Infections ........................................................................ 429
Chapter 58: Adult And Pediatric Emergency Drugs .................................................................................. 433
, TEST BANK PHARMACOLOGY A PATIENT-CENTERED
NURSING PROCESS APPROACH, 11TH EDITION BY LINDA
E. MCCUISTION CHAPTER 1-58
Chapter 01: The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
MULTIPLE CHOICE
1. All Of The Following Would Be Considered Subjective Data, EXCEPT:
A. Patient-Reported Health History
B. Patient-Reported Signs And Symptoms Of Their Illness
C. Financial Barriers Reported By The Patient’s Caregiver
D. Vital Signs Obtained From The Medical Record
CORRECT ANSWER: D
Subjective Data Is Based On What Patients Or Family Members Communicate To The Nurse. Patient-
Reported Health History, Signs And Symptoms, And Caregiver Reported Financial Barriers Would Be
Considered Subjective Data. Vital Signs Obtained From The Medical Record Would Be Considered
Objective Data.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning MSC:
NCLEX: Management Of Client Care
2. The Nurse Is Using Data Collected To Define A Set Of Interventions To Achieve The Most
Desirable Outcomes. Which Of The Following Steps Is The Nurse Applying?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Generate Solutions (Planning)
D. Take Action (Nursing Interventions)
CORRECT ANSWER: C
When Generating Solutions (Planning), The Nurse Identifies Expected Outcomes And Uses The Patient’s
Problem(S) To Define A Set Of Interventions To Achieve The Most Desirable Outcomes. Recognizing Cues
(Assessment) Involves The Gathering Of Cues (Information) From The Patient About Their Health And
APPROACH, 11TH EDITION BY LINDA E. MCCUISTION CHAPTER 1-58
,Table Of Contents
Chapter 01: The Nursing Process And Patient-Centered Care...................................................................... 4
Chapter 02: Drug Development And Ethical Considerations ...................................................................... 11
Chapter 03: Pharmacokinetics And Pharmacodynamics ............................................................................ 20
Chapter 04: Pharmacogenetics ................................................................................................................... 38
Chapter 05: Complementary And Alternative Therapies ........................................................................... 42
Chapter 06: Pediatric Considerations ......................................................................................................... 48
Chapter 07: Geriatric Considerations ......................................................................................................... 57
Chapter 08: Drugs In Substance Use Disorder ............................................................................................ 63
Chapter 09: Safety And Quality................................................................................................................... 70
Chapter 10: Drug Administration ................................................................................................................ 78
Chapter 11: Drug Calculations .................................................................................................................... 84
Chapter 12: Fluid Volume And Electrolytes ................................................................................................ 89
Chapter 13: Vitamin And Mineral Replacement ....................................................................................... 100
Chapter 14: Nutritional Support ............................................................................................................... 109
Chapter 15: Adrenergic Agonists And Antagonists ................................................................................... 118
Chapter 16: Cholinergic Agonists And Antagonists .................................................................................. 125
Chapter 17: Stimulants ............................................................................................................................. 133
Chapter 18: Depressants ........................................................................................................................... 139
Chapter 19: Antiseizure Drugs .................................................................................................................. 147
Chapter 20: Drugs For Parkinsonism And Alzheimer Disease................................................................... 155
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms .................................................... 163
Chapter 22: Antipsychotics And Anxiolytics ............................................................................................. 170
Chapter 23: Antidepressants And Mood Stabilizers ................................................................................. 179
Chapter 24: Antiinflammatories ............................................................................................................... 188
Chapter 25: Analgesics .............................................................................................................................. 197
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins .......................................................... 205
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides... 211
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones Mccuistion: ........... 216
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics ..................................................................... 221
Chapter 30: Antituberculars, Antifungals, And Antivirals ......................................................................... 227
Chapter 31: Antimalarials, Anthelmintics, And Peptides .......................................................................... 237
Chapter 32: HIV- And AIDS-Related Drugs ................................................................................................ 241
,Chapter 33: TrCorrect Answerplant Drugs................................................................................................ 246
Chapter 34: Vaccines................................................................................................................................. 249
Chapter 35: Anticancer Drugs ................................................................................................................... 255
Chapter 36: Targeted Therapies To Treat Cancer ..................................................................................... 260
Chapter 37: Biologic Response Modifiers ................................................................................................. 265
Chapter 38: Upper Respiratory Disorders................................................................................................. 271
Chapter 39: Lower Respiratory Disorders ................................................................................................. 278
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics ..................................................... 288
Chapter 41: Diuretics ................................................................................................................................ 299
Chapter 42: Antihypertensives ................................................................................................................. 305
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics................................................................ 314
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow Mccuistion: ................. 324
Chapter 45: Gastrointestinal Tract Disorders ........................................................................................... 332
Chapter 46: Antiulcer Drugs...................................................................................................................... 342
Chapter 47: Eye And Ear Disorders ........................................................................................................... 352
Chapter 48: Dermatologic Disorders ........................................................................................................ 357
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders ....................................................... 364
Chapter 50: Antidiabetics ......................................................................................................................... 376
Chapter 51: Urinary Disorders .................................................................................................................. 385
Chapter 52: Pregnancy And Preterm Labor .............................................................................................. 393
Chapter 53: Labor, Delivery, And Postpartum .......................................................................................... 403
Chapter 54: Neonatal And Newborn ........................................................................................................ 410
Chapter 55: Women’s Reproductive Health ............................................................................................. 413
Chapter 56: Men’s Health And Reproductive Disorders ........................................................................... 422
Chapter 57: Sexually TrCorrect Answermitted Infections ........................................................................ 429
Chapter 58: Adult And Pediatric Emergency Drugs .................................................................................. 433
, TEST BANK PHARMACOLOGY A PATIENT-CENTERED
NURSING PROCESS APPROACH, 11TH EDITION BY LINDA
E. MCCUISTION CHAPTER 1-58
Chapter 01: The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
MULTIPLE CHOICE
1. All Of The Following Would Be Considered Subjective Data, EXCEPT:
A. Patient-Reported Health History
B. Patient-Reported Signs And Symptoms Of Their Illness
C. Financial Barriers Reported By The Patient’s Caregiver
D. Vital Signs Obtained From The Medical Record
CORRECT ANSWER: D
Subjective Data Is Based On What Patients Or Family Members Communicate To The Nurse. Patient-
Reported Health History, Signs And Symptoms, And Caregiver Reported Financial Barriers Would Be
Considered Subjective Data. Vital Signs Obtained From The Medical Record Would Be Considered
Objective Data.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning MSC:
NCLEX: Management Of Client Care
2. The Nurse Is Using Data Collected To Define A Set Of Interventions To Achieve The Most
Desirable Outcomes. Which Of The Following Steps Is The Nurse Applying?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Generate Solutions (Planning)
D. Take Action (Nursing Interventions)
CORRECT ANSWER: C
When Generating Solutions (Planning), The Nurse Identifies Expected Outcomes And Uses The Patient’s
Problem(S) To Define A Set Of Interventions To Achieve The Most Desirable Outcomes. Recognizing Cues
(Assessment) Involves The Gathering Of Cues (Information) From The Patient About Their Health And
